Disconnected senior management, disconnect between company philosophy and culture and behavior of senior mangement, especially with regard to ethics and oncology staff was instrumential in the success of several treatments only to have senior executives decide they could capitialize on their employees' sweat equity to swap assets with Novaritis for approx $16 billion dollars. The senior management and some middle managers at GSK are quite cut-throat, don't look out at all for their employees, can't understand why telecommuting would make the company more competitive and cut-costs without severe adverse effects on staff and micro-manage.
Lack of meaningful career advancement due to changes in job grades and the old girl and old boy networks. If you are not part of the Queen Bee hive, you are likely to languish in your current position.
With the current turbulence at GSK, I suggest folks take a pass until the dust settles sometime in 2015. If you care about ethics at a company, I'd take a pass on GSK for the time being.
